MedTrace Logo

Antidepressant Treatment Plus Cognitive Behavioral Therapy for Generalized Anxiety Disorder in Older Adults

NCT00601965 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 73

Last updated 2016-08-25

Study results available
· View outcomes & findings →

Summary

This study will assess whether adding cognitive behavioral therapy to the antidepressant escitalopram is effective in reducing anxiety in older adults with generalized anxiety disorder.

Conditions

  • Generalized Anxiety Disorder

Interventions

DRUG

Escitalopram

20 mg daily oral escitalopram

DRUG

Placebo

Placebo pill of daily oral escitalopram

BEHAVIORAL

Cognitive behavioral therapy (CBT)

16 weekly 1-hour sessions

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Veterans Medical Research Foundation

    lead OTHER

Principal Investigators

  • Julie L. Wetherell, PhD · UCSD and VMRF/VASDHS

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2011-09-30
Completion
2011-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00601965 on ClinicalTrials.gov